Ella H. Sklan
- Hepatology top 2%
- Hepatitis C virus research 13
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases 12
- Virology top 5%
- Infectious Diseases top 5%
- Viral Infections and Vectors 6
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease 6
-
- Mosquito-borne diseases and control 12
-
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 8
-
- Computational Drug Discovery Methods 7
- Co-authors
- Hermona SoreqJeffrey S. GlennShirit EinavMenashe ElazarChava PerryErez PodolyKlara R. BirikhJae U. Jung
- Cited by
- HepatologyPharmacologyVirology
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ella H. Sklan
58 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 123
- Hepatology 425
- Pharmacology 432
- Virology 114
- Infectious Diseases 354
- Cell Biology 246
Countries citing papers authored by Ella H. Sklan
This map shows the geographic impact of Ella H. Sklan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella H. Sklan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella H. Sklan more than expected).
Fields of papers citing papers by Ella H. Sklan
This network shows the impact of papers produced by Ella H. Sklan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella H. Sklan. The network helps show where Ella H. Sklan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ella H. Sklan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 26 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 64 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 28 | |
| 12 | 2020 | 16 | |
| 13 | 2015 | 22 | |
| 14 | 2011 | 62 | |
| 15 | 2008 | 31 | |
| 16 | 2007 | 4 | |
| 17 | 2006 | 55 | |
| 18 | 2006 | 109 | |
| 19 | 2002 | 77 | |
| 20 | 2000 | 1 |
About Ella H. Sklan
Ella H. Sklan is a scholar working on Hepatology, Virology and Pharmacology, having authored 61 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (13 papers), Mosquito-borne diseases and control (12 papers), Cholinesterase and Neurodegenerative Diseases (12 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (8 papers), Computational Drug Discovery Methods (7 papers), Viral Infections and Vectors (6 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). The work is most often cited by research in Hepatology (425 citations), Pharmacology (432 citations) and Virology (114 citations). Ella H. Sklan has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Hermona Soreq, Jeffrey S. Glenn, Shirit Einav, Menashe Elazar, Chava Perry, Erez Podoly, Klara R. Birikh, Jae U. Jung, Amir Shlomai and Shai Shoham. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.